2025-03-11 22:58:10
Latest Post
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Hexaware Inaugurates Global Business Headquarters in Jersey City
HCLTech among Ethisphere's 2025 World's Most Ethical Companies®
Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
Stock Report
Unichem Laboratories Q3FY22 consolidated loss at Rs. 14.10 crore
Posted On : 2022-01-29 20:48:22( TIMEZONE : IST )
Unichem Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 325.9637 crores during the period ended December 31, 2021 as compared to Rs. 293.3126 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -14.1048 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -12.8168 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -2.01 for the period ended December 31, 2021 as compared to Rs. -1.82 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 325.9637 crs | ₹293.3126 crs |  11.13% |
| Net Profit | ₹-14.1048 crs | ₹-12.8168 crs |  10.05% |
| EPS | ₹-2.01 | ₹-1.82 | 10.44% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 325.9637 crores during the period ended December 31, 2021 as compared to Rs.341.8908 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-14.1048 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.23.5608 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-2.01 for the period ended December 31, 2021 as compared to Rs.3.35 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 325.9637 crs | ₹341.8908 crs |  -4.66% |
| Net Profit | ₹-14.1048 crs | ₹23.5608 crs | -159.87% |
| EPS | ₹-2.01 | ₹3.35 | -160.00% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.932.9975 crores during the 9 Months period ended December 31, 2021 as compared to Rs.1003.3747 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-38.4104 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.34.7334 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-5.46 for the 9 Months period ended December 31, 2021 as compared to Rs.4.93 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹932.9975 crs | ₹1003.3747 crs | -7.01% |
| Net Profit | ₹-38.4104 crs | ₹34.7334 crs | -210.59% |
| EPS | ₹-5.46 | ₹4.93 | -210.75% |
Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 279.80 as compared to the previous close of Rs. 273.25. The total number of shares traded during the day was 36592 in over 2886 trades.
The stock hit an intraday high of Rs. 288.00 and intraday low of 273.05. The net turnover during the day was Rs. 10164259.00.
